Publisher Correction: Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9

被引：0
|
作者：
Jelka Pohar
Duško Lainšček
Ana Kunšek
Miša-Mojca Cajnko
Roman Jerala
Mojca Benčina
机构：
[1] National Institute of Chemistry,Department of Synthetic Biology and Immunology
[2] Centre of Excellence EN-FIST,undefined
来源：
Scientific Reports | / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.
引用
收藏
相关论文
共 50 条
  • [31] The Toll-like receptor ligand, CpG oligodeoxynucleotides, regulate proliferation and osteogenic differentiation of osteoblast
    Wenwen Yu
    Yi Zheng
    Hongyan Li
    Hongbing Lin
    Zhen Chen
    Yue Tian
    Huishan Chen
    Peipei Zhang
    Xiaowei Xu
    Yuqin Shen
    Journal of Orthopaedic Surgery and Research, 15
  • [32] Bacterial peptidoglycans but activate synovial fibroblasts not CpG oligodeoxynucleotides by toll-like receptor signaling
    Kyburz, D
    Rethage, J
    Seibl, R
    Lauener, R
    Gay, RE
    Carson, DA
    Gay, S
    ARTHRITIS AND RHEUMATISM, 2003, 48 (03): : 642 - 650
  • [33] Phosphorothioate-modified CpG oligodeoxynucleotides mimic autoantigens and reveal a potential role for Toll-like receptor 9 in receptor revision
    Doster, Anne
    Ziegler, Saskia
    Foermer, Sandra
    Rieker, Ralf Joachim
    Heeg, Klaus
    Bekeredjian-Ding, Isabelle
    IMMUNOLOGY, 2013, 139 (02) : 166 - 178
  • [34] A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases
    Kaveri Gupta
    Curtis Cooper
    Drugs in R & D, 2008, 9 : 137 - 145
  • [35] Intracellular processing of immunostimulatory CpG-siRNA: Toll-like receptor 9 facilitates siRNA dicing and endosomal escape
    Nechaev, Sergey
    Gao, Chan
    Moreira, Dayson
    Swiderski, Piotr
    Jozwiak, Agnieszka
    Kowolik, Claudia M.
    Zhou, Jiehua
    Armstrong, Brian
    Raubitschek, Andrew
    Rossi, John J.
    Kortylewski, Marcin
    JOURNAL OF CONTROLLED RELEASE, 2013, 170 (03) : 307 - 315
  • [36] A review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseases
    Gupta, Kaveri
    Cooper, Curtis
    DRUGS IN R&D, 2008, 9 (03) : 137 - 145
  • [37] Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity
    Peter, Mirjam
    Bode, Konrad
    Lipford, Grayson B.
    Eberle, Florian
    Heeg, Klaus
    Dalpke, Alexander H.
    IMMUNOLOGY, 2008, 123 (01) : 118 - 128
  • [38] Effects of Toll-like receptor 9 and CpG oligodeoxynucleotides 1826 on sodium taurocholate-induced acute pancreatitis rats
    Sun, Liang
    Li, Yuanhua
    Luo, Huayou
    Wang, Kunhua
    Li, Li
    Zeng, Yujian
    MOLECULAR MEDICINE REPORTS, 2018, 18 (04) : 3818 - 3824
  • [39] Toll-like receptor 9 mediates CpG-DNA signaling
    Chuang, TH
    Lee, J
    Kline, L
    Mathison, JC
    Ulevitch, RJ
    JOURNAL OF LEUKOCYTE BIOLOGY, 2002, 71 (03) : 538 - 544
  • [40] Direct binding of Toll-like receptor 9 to CpG-DNA
    不详
    IMMUNOBIOLOGY, 2004, 209 (4-6) : 324 - 324
12345